Researchers in Taiwan have developed a new targeted therapy drug that preclinical trials suggest could inhibit the growth of tumors in nearly 30 percent of cancer patients.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Go star Hsu Hao-hung wins Taiwan's 2025 "Mr. Popular" and MVP Awards
01/09/2026 04:44 PM - Business
Taiwan shares end down but come off low ahead of TSMC's sales
01/09/2026 04:43 PM - Business
U.S. dollar closes higher on Taipei forex market
01/09/2026 04:14 PM - Business
TSMC reports record high sales for 2025, up over 31%
01/09/2026 03:47 PM - Politics
Opposition again blocks defense, general budgets in Legislature
01/09/2026 03:43 PM